ZIG
AMED

Zullo Investment Group’s Amedisys AMED Stock Holding History

Zullo Investment Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250
Closed -$20.9K – 154
2022
Q4 		$20.9K Hold
250
– – 0.01% 389
2022
Q3 		$24K Hold
250
– – 0.02% 363
2022
Q2 		$26K Hold
250
– – 0.02% 359
2022
Q1 		$43K Hold
250
– – 0.02% 315
2021
Q4 		$40K Buy
+250
New +$40.2K 0.02% 332

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Zullo Investment Group's AMED Position: Q1 2023 in Review

Zullo Investment Group sold out of Amedisys (AMED) in Q1 2023, closing a stake of 250 shares — an estimated $20.9K sold.

Zullo Investment Group first reported a position in AMED in Q4 2021 and held it in 5 quarters. The position peaked at $43K in Q1 2022. 281 funds tracked by Wall St. Rank hold AMED as of Q1 2023.

  • Zullo Investment Group reported no remaining Amedisys position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 250 Amedisys shares in Q1 2023, an estimated $20.9K.
  • Zullo Investment Group first reported a position in Amedisys in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Amedisys position peaked at $43K in Q1 2022.
  • 281 funds tracked by Wall St. Rank held Amedisys as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.